Revolutionizing Healthcare: Redi Health's Major Funding, AI advancements by NuraLogix and Neurable, and Novo Nordisk's Bold Acquisition

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/aa/a9/cb/aaa9cbcf-e662-f866-9474-e5ada25f8aad/mza_10736519076039578761.jpg/600x600bb.jpg

MedTech AI Daily: The Commercial Brief

Stan Berteloot

18 episodes

1 day ago

MedTech AI Daily is the morning briefing for commercial leaders, marketing executives, and heads of growth in medical devices who need to separate signal from noise on AI. In 10 minutes, we cover how AI is changing the business of selling, not just the science of building: • AI in commercial strategy How leading manufacturers use AI to modernize targeting, field execution, and marketing. • Regulatory moves that matter What FDA AI/ML clearances mean for speed to market and how they change launch planning. • Digital transformation in practice Real use cases of generative AI in HCP engagement, field enablement, and patient adoption. • Market moves to watch M&A, partnerships, and competitor initiatives that define where digital health is heading next. You get practical intelligence you can use in your pipeline, plans, and board decks. Not demo theater. Hosted by Stan Berteloot

All content for MedTech AI Daily: The Commercial Brief is the property of Stan Berteloot and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Revolutionizing Healthcare: Redi Health's Major Funding, AI advancements by NuraLogix and Neurable, and Novo Nordisk's Bold Acquisition

MedTech AI Daily: The Commercial Brief

4 minutes

1 year ago

Revolutionizing Healthcare: Redi Health's Major Funding, AI advancements by NuraLogix and Neurable, and Novo Nordisk's Bold Acquisition

On today's episode of AI in Life Sciences, we cover Redi Health's fruitful Series B funding round, and its plans to revolutionize healthcare using tech-integrated solutions. We delve into the groundbreaking use of digital twins powered by AI in cost reduction, advanced disease detection, personalized medicine, and optimization of operations in the healthcare sector. We also introduce NuraLogix's Anura MagicMirror, an innovative smart device that uses facial blood flow data for vital sign calculations and disease risk assessments. Next, we discuss the Children's Hospital Los Angeles's ambient AI assistant, Nabla Copilot, and its role in reducing practitioner stress and improving patient care. We explore the partnership between Neurable and Healthspan Digital, broadening access to the ground-breaking brain-computer interface tech. And finally, we unveil Novo Nordisk's acquisition of Cardior Pharmaceuticals, expanding its cardiometabolic medicine pipeline.